Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-10-09
2011-12-06
Anderson, James (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S159000
Reexamination Certificate
active
08071621
ABSTRACT:
Compounds of Formula Iwherein R1, A, R2, R3, R4, R5, R8, n, m, q and r are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
REFERENCES:
patent: 5177096 (1993-01-01), Keenan et al.
patent: 5248689 (1993-09-01), Girard et al.
patent: 5444081 (1995-08-01), Gleason et al.
patent: 5686455 (1997-11-01), Adams et al.
patent: 5811553 (1998-09-01), Farina et al.
patent: 5942523 (1999-08-01), Bichon et al.
patent: 6057362 (2000-05-01), Yamashita
patent: 6232342 (2001-05-01), Carr et al.
patent: 6277862 (2001-08-01), Giardina et al.
patent: 6387898 (2002-05-01), Feuerstein et al.
patent: 6608083 (2003-08-01), Farina et al.
patent: 6743804 (2004-06-01), Giardina et al.
patent: 6858630 (2005-02-01), Luengo et al.
patent: 7253286 (2007-08-01), Funahashi et al.
patent: 2003/0195204 (2003-10-01), Giardina et al.
patent: 2004/0006135 (2004-01-01), Sobolov-Jaynes et al.
patent: 2007/0254886 (2007-11-01), Habashita et al.
patent: 1192952 (2002-04-01), None
patent: 0804419 (2003-08-01), None
patent: 0940391 (2004-08-01), None
patent: 9532948 (1995-12-01), None
patent: 9602509 (1996-02-01), None
patent: 97/19927 (1997-06-01), None
patent: 97/21680 (1997-06-01), None
patent: 9719926 (1997-06-01), None
patent: 9719928 (1997-06-01), None
patent: 9951565 (1999-10-01), None
patent: 0012497 (2000-03-01), None
patent: 0031037 (2000-06-01), None
patent: 0064877 (2000-11-01), None
patent: 0213825 (2002-02-01), None
patent: 0238548 (2002-05-01), None
patent: 02094187 (2002-11-01), None
patent: 2004000355 (2003-12-01), None
patent: 2004050626 (2004-06-01), None
patent: 2004050627 (2004-06-01), None
patent: 2004087153 (2004-10-01), None
patent: 2005014532 (2005-02-01), None
patent: 2005014533 (2005-02-01), None
patent: 2005014534 (2005-02-01), None
patent: 2005094801 (2005-10-01), None
patent: 2005108359 (2005-11-01), None
patent: 2006/050991 (2006-05-01), None
patent: 2006/120478 (2006-11-01), None
patent: 2006137789 (2006-12-01), None
patent: 2007022059 (2007-02-01), None
patent: 2008021388 (2008-02-01), None
Giardina, et al., Discovery of a novel Class of Selective Non-Peptide Antagonists for the Human Neurikinin-3Receptor. 2. Identification of (S)-N-(1-Phenylpropyl)-3-Hydroxy-2-Phenylquinoline-4-Carboxamide (SB 223412), Journal of Med. Chem., 1999, vol. 42, pp. 1053-1065.
Memorandum dated Apr. 6, 2006 regarding U.S. Appl. No. 6,608,083 which was filed May 25, 1995.
Jeffrey S. Albert, “Neurokinin antagonists and their potential role in treating depression and other stress disorders,” Expert Opin. Ther. Patents, 14(10), pp. 1421-33 (2004).
Jeffrey S. Albert, et. al., “Neurokinin-3 receptor antagonists in schizophrenia”, Expert Opin. Ther. Patents, 16 (7), pp. 925-37 (2006).
Albert Jeffrey
Alhambra Cristobal
Kang James
Koether Gerard
Li Yan
Anderson James
AstraZeneca AB
Baek Bong-Sook
Mitchell Kenneth F.
LandOfFree
Alkylsulphonamide quinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylsulphonamide quinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylsulphonamide quinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4310396